NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

AMGN

AMGEN Inc

May 12 • 04:00PM ET

274.76

Dollar change +8.90
Percentage change 3.35	%

Healthcare • Drug Manufacturers - General • USA • NASD

Peers: BIIB GILD REGN VRTX BMY MRNA ILMN PFE NBIX ABBV

| Held by: VTI VOO QQQ SCHD SPY IVV DIA VTV XLV VIG

Scroll to Statements

Index	DJIA, NDX, S&P 500	P/E	25.08	EPS (ttm)	10.95	Insider Own	0.21%	Shs Outstand	537.70M	Perf Week	-1.89%
Market Cap	147.74B	Forward P/E	12.78	EPS next Y	21.51	Insider Trans	-6.70%	Shs Float	536.56M	Perf Month	-2.36%
Income	5.93B	PEG	5.89	EPS next Q	5.27	Inst Own	79.38%	Short Float	2.72%	Perf Quarter	-6.79%
Sales	33.93B	P/S	4.35	EPS this Y	4.90%	Inst Trans	1.57%	Short Ratio	4.73	Perf Half Y	-14.62%
Book/sh	11.54	P/B	23.80	EPS next Y	3.33%	ROA	6.51%	Short Interest	14.62M	Perf Year	-10.59%
Cash/sh	16.38	P/C	16.77	EPS next 5Y	4.26%	ROE	105.67%	52W Range	253.30 - 346.85	Perf YTD	5.42%
Dividend Est.	9.73 (3.54%)	P/FCF	13.54	EPS past 5Y	-10.10%	ROI	9.85%	52W High	-20.78%	Beta	0.51
Dividend TTM	9.13 (3.32%)	Quick Ratio	0.88	Sales past 5Y	7.57%	Gross Margin	67.43%	52W Low	8.47%	ATR (14)	9.40
Dividend Ex-Date	May 16, 2025	Current Ratio	1.17	EPS Y/Y TTM	56.99%	Oper. Margin	26.26%	RSI (14)	43.17	Volatility	3.36% 3.04%
Employees	28000	Debt/Eq	9.24	Sales Y/Y TTM	15.59%	Profit Margin	17.49%	Recom	2.41	Target Price	312.09
Option/Short	Yes / Yes	LT Debt/Eq	8.70	EPS Q/Q	1616.98%	Payout	119.05%	Rel Volume	1.36	Prev Close	265.86
Sales Surprise	1.14%	EPS Surprise	14.76%	Sales Q/Q	9.42%	Earnings	May 01 AMC	Avg Volume	3.09M	Price	274.76
SMA20	-1.98%	SMA50	-7.51%	SMA200	-8.99%	Trades		Volume	4,214,518	Change	3.35%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-22-25	Resumed	Cantor Fitzgerald	Neutral	$305
Dec-10-24	Resumed	BofA Securities	Underperform	$256
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-14-24	Initiated	Citigroup	Neutral	$335
Oct-17-24	Initiated	Bernstein	Outperform	$380
Oct-14-24	Downgrade	Truist	Buy → Hold	$320 → $333
Sep-27-24	Initiated	Cantor Fitzgerald	Overweight	$405
Aug-07-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$320 → $335
May-03-24	Upgrade	William Blair	Mkt Perform → Outperform
May-03-24	Upgrade	Barclays	Underweight → Equal Weight	$230 → $300
Mar-28-24	Resumed	Raymond James	Mkt Perform
Feb-07-24	Downgrade	Leerink Partners	Outperform → Market Perform	$324 → $318
Dec-21-23	Upgrade	Daiwa Securities	Neutral → Buy	$264 → $320
Dec-19-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$286 → $326
Dec-12-23	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$256 → $300
Nov-09-23	Initiated	Deutsche Bank	Hold	$240
Nov-02-23	Upgrade	Truist	Hold → Buy	$260 → $320
Oct-20-23	Resumed	JP Morgan	Neutral	$265 → $270
Oct-17-23	Resumed	Morgan Stanley	Equal-Weight	$300
Oct-11-23	Resumed	BofA Securities	Neutral	$290

Show Previous Ratings

Today 07:20PM	Trump's drug price order is part request, part threat: Analyst (Yahoo Finance Video)
04:25PM	S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite' (Investor's Business Daily)
03:50PM	How Trump could go about executing order to slash drug prices (Yahoo Finance Video)
10:00AM	S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Outlines Drug-Price Reform (Investor's Business Daily)
09:37AM	Pharma Stocks Hit by Trump's Vow to Cut US Prescription Drug Costs (Zacks)
09:10AM	Loading…
09:10AM	3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income (Zacks)
May-09-25 04:01PM	AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
06:20AM	Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? (Zacks)
May-08-25 09:53AM	2 Unstoppable Dividend Stocks to Buy and Hold Forever (Motley Fool)
May-07-25 04:51PM	Trump planning on Executive Order to further cut Medicare drug prices - report (Seeking Alpha)
02:52PM	Amgen Inc. (AMGN): A Bull Case Theory (Insider Monkey)
02:18PM	Is Amgen Inc. (AMGN) the Best Dow Stock? (Insider Monkey)
02:16PM	Amgen's Tepezza becomes first U.K.-medicine approved for adults with thyroid eye disease (Seeking Alpha)
09:45AM	Here's Why Amgen (AMGN) is a Strong Growth Stock (Zacks)
May-06-25 08:18PM	Analyst Report: Amgen Inc. (Morningstar Research)
09:40AM	Loading…
09:40AM	Here's Why Amgen (AMGN) is a Strong Value Stock (Zacks)
May-05-25 09:10AM	3 Top Dividend Stocks to Maximize Your Retirement Income (Zacks)
09:00AM	Is Trending Stock Amgen Inc. (AMGN) a Buy Now? (Zacks)
08:01AM	AMGN's Key Drugs Repatha, Evenity & Blincyto Drive Q1 Sales Growth (Zacks)
May-04-25 10:30AM	Amgen: Reducing My Price Target, Reiterate Buy After A Solid Q1 (Seeking Alpha)
May-03-25 09:46AM	Dogs Of The Dow Chase May's 'Safer' Buy (Seeking Alpha)
May-02-25 02:15PM	Committee Movers: Eaton Corp PLC, Blackstone, Amgen, EOG Resources, Chevron and Exxon Mobile (CNBC TV)
09:07AM	Analyst Report: Amgen Inc. (Morningstar Research)
08:16AM	Amgens Stelara biosimilar gets off to fast start (BioPharma Dive)
08:14AM	Q1 2025 Amgen Inc Earnings Call (Thomson Reuters StreetEvents)
07:50AM	Amgen's Q1 Earnings Beat Estimates, Key Drugs Drive Sales Growth (Zacks)
07:02AM	3 Biotech Giants Gaining From U.S. Sales and Policy Shifts (MarketBeat)
03:15AM	Amgen Inc (AMGN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Pricing Challenges (GuruFocus.com)
May-01-25 08:42PM	Amgen Inc. (AMGN) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:30PM	Compared to Estimates, Amgen (AMGN) Q1 Earnings: A Look at Key Metrics (Zacks)
05:10PM	Loading…
05:10PM	Amgen (AMGN) Tops Q1 Earnings and Revenue Estimates (Zacks)
04:41PM	Amgen beats Q1 expectations, issues solid full-year outlook (Investing.com)
04:22PM	Amgen posts profit, says tax policy more effective than tariffs (Reuters)
04:20PM	Amgen beats Q1 earnings, revenue estimates. Stock flat. (Yahoo Finance Video)
04:08PM	Amgen: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	AMGEN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS (PR Newswire)
11:09AM	Initial Claims More Than Expectations (Zacks)
10:34AM	Jobless Claims Higher; Q1 Earnings from LLY, MCD & More (Zacks)
08:30AM	Beat the Nasdaq With This Cash-Gushing Dividend Stock (Motley Fool)
Apr-30-25 07:00PM	Amazon and Apple earnings coverage, Eli Lilly: What to Watch (Yahoo Finance Video)
02:35PM	Is Amgen Inc. (AMGN) the Best Dow Stock for the Next 12 Months? (Insider Monkey)
12:10PM	Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Apr-29-25 10:20AM	Novo Nordisk Before Q1 Earnings: How Should Investors Play the Stock? (Zacks)
10:01AM	Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should Know (Zacks)
09:12AM	AZN Q1 Earnings Beat, Stock Down on Soft Sales Performance of Key Drugs (Zacks)
06:42AM	Can Amgen Keep the Beat Streak Alive This Earnings Season? (Zacks)
06:32AM	The Zacks Analyst Blog Highlights Pfizer, Eli Lilly, Amgen, Biogen and Regeneron (Zacks)
06:20AM	Should You Invest in the VanEck Biotech ETF (BBH)? (Zacks)
Apr-28-25 05:33PM	Zymeworks: A Strong Buy With Newly-Approved Cancer Drug, Excellent Financials, And Expansive Pipeline (Seeking Alpha)
04:01PM	AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS (PR Newswire)
12:08PM	Will These 5 Big Drug Stocks Surpass Q1 Earnings Forecasts? (Zacks)
11:41AM	Is Eli Lilly Stock a Portfolio Must-Have Pre-Q1 Earnings? (Revised) (Zacks)
11:20AM	Eli Lilly, Pfizer Risk Billions in Losses From Trump's 25% Pharma Tariffs (GuruFocus.com)
09:15AM	Amgen (AMGN) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
09:10AM	3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income (Zacks)
07:45AM	Is Eli Lilly Stock a Portfolio Must-Have Pre-Q2 Earnings? (Zacks)
06:37AM	Amgen to invest $900m in Ohio manufacturing facility (Pharmaceutical Technology)
Apr-27-25 11:40PM	Why AbbVie's Stock Is A Strong Buy After Q1 2025 Results (Seeking Alpha)
06:00AM	What To Expect in the Markets This Week (Investopedia)
Apr-26-25 06:05PM	4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off (Motley Fool)
08:50AM	Novo Nordisk: Examining Tariff And Pricing Risks (Seeking Alpha)
Apr-25-25 05:06PM	Pharma reshoring: Amgen invests $900M in Ohio biotech facility (Yahoo Finance Video)
01:12PM	Amgen to expand Ohio biotech manufacturing plant (Reuters)
12:47PM	AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIO (PR Newswire)
10:14AM	CytomX Gears Up to Report Q1 Earnings: Here's What to Expect (Zacks)
Apr-24-25 04:22PM	Q1 Earnings Scorecard and Analyst Reports for Costco, American Express & Goldman Sachs (Zacks)
11:18AM	Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock? (Zacks)
10:01AM	Amgen (AMGN) Earnings Expected to Grow: Should You Buy? (Zacks)
07:46AM	Johnson & Johnson Just Proved The Bears Wrong Again (Seeking Alpha)
Apr-22-25 09:53AM	3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold (Motley Fool)
09:49AM	Is Amgen Inc. (AMGN) a Cheap NASDAQ Stock to Buy According to Hedge Funds? (Insider Monkey)
09:48AM	Cantor initiates coverage of U.S. large-cap pharma stocks: Gilead, AbbVie at Buy (Investing.com)
Apr-21-25 05:50PM	Amgen (AMGN) Stock Moves -1.3%: What You Should Know (Zacks)
02:24PM	Final Trades: Take-Two Interactive, Franco-Nevada, Amgen and the 10-Year Treasury (CNBC TV)
09:10AM	3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income (Zacks)
09:00AM	Is Most-Watched Stock Amgen Inc. (AMGN) Worth Betting on Now? (Zacks)
08:21AM	Should You Buy, Sell or Hold AstraZeneca Stock Before Q1 Earnings? (Zacks)
Apr-18-25 09:40AM	Here's Why Amgen (AMGN) is a Strong Value Stock (Zacks)
Apr-17-25 06:18PM	Short Week Finishes with Netflix Q1 Beat (Zacks)
06:00PM	Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know (Zacks)
11:36AM	Wall Street Lunch: Obesity Pill Progress (Seeking Alpha)
10:12AM	Health Insurance Stocks Drop After UnitedHealth Forecast News (Investopedia)
09:45AM	Amgen Inc. (AMGN): Among the Innovative Healthcare Stocks to Watch in 2025 (Insider Monkey)
08:56AM	2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever (Motley Fool)
08:15AM	Amgen: The Biotech That Knows How To Make Money (Seeking Alpha)
08:03AM	Here's How You Should Play JNJ Stock After Q1 Earnings Beat (Zacks)
06:20AM	Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? (Zacks)
06:20AM	Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? (Zacks)
Apr-16-25 02:41PM	IYH: Healthcare Dashboard For April (Seeking Alpha)
07:05AM	Eli Lilly Stock Down 8.2% in a Month: Should You Buy the Dip? (Zacks)
05:56AM	Leqembi finally secures EU clearance; Sandoz sues Amgen over Enbrel patents (BioPharma Dive)
Apr-15-25 11:20PM	Aristotle Global Equity Q1 2025 Commentary (Seeking Alpha)
11:14AM	JNJ Tops Q1 Earnings, Ups '25 Sales View to Include Intra-Cellular Deal (Zacks)
Apr-14-25 09:10AM	3 Top Dividend Stocks to Maximize Your Retirement Income (Zacks)
06:59AM	Sandoz challenges Amgens Enbrel patents in US antitrust lawsuit (Pharmaceutical Technology)
05:27AM	Amgens Phase III trial of Imdelltra meets primary endpoint for SCLC (Clinical Trials Arena)
01:12AM	Sandoz files U.S. antitrust lawsuit against Amgen over arthritis drug (Reuters)
Apr-13-25 02:12PM	DJD: Dividend And Value In Mega Caps (Seeking Alpha)
09:15AM	SCHD's Portfolio Shake-Up: What It Means For Investors (Rating Downgrade) (Seeking Alpha)
Apr-12-25 08:30AM	How To Buy Low And Sell High Consistently For Lifelong Wealth (Seeking Alpha)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Busch Matthew C.	VP, Finance & CAO	May 02 '25	Sale	279.69	1,000	279,690	4,034	May 06 08:07 PM
Busch Matthew C.	Officer	May 02 '25	Proposed Sale	281.44	1,000	281,440		May 02 02:37 PM
Santos Esteban	EVP, Operations	Feb 19 '25	Option Exercise	156.35	8,711	1,361,965	80,257	Feb 21 08:07 PM
Santos Esteban	EVP, Operations	Feb 19 '25	Sale	292.84	8,711	2,550,903	71,546	Feb 21 08:07 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 19 '25	Option Exercise	156.35	8,711	1,361,965	70,858	Feb 21 08:06 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 21 '25	Sale	304.44	25,225	7,679,524	36,922	Feb 21 08:06 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 19 '25	Sale	293.22	8,711	2,554,224	62,147	Feb 21 08:06 PM
DAVID M REESE & JOAN I CHUCO-T	Officer	Feb 21 '25	Proposed Sale	304.44	25,225	7,679,524		Feb 21 04:27 PM
Miller Derek	SVP, Human Resources	Feb 19 '25	Option Exercise	156.35	1,524	238,277	10,068	Feb 20 08:59 PM
Miller Derek	SVP, Human Resources	Feb 19 '25	Sale	293.74	1,524	447,655	8,544	Feb 20 08:59 PM
Miller Derek	SVP, Human Resources	Feb 18 '25	Sale	292.56	500	146,279	8,544	Feb 20 08:59 PM
DEREK MILLER	Officer	Feb 19 '25	Proposed Sale	293.74	1,524	447,655		Feb 19 04:18 PM
DAVID REESE	Officer	Feb 19 '25	Proposed Sale	293.22	8,711	2,554,224		Feb 19 04:14 PM
Santos Esteban	Affiliate	Feb 19 '25	Proposed Sale	292.11	8,711	2,544,570		Feb 19 02:25 PM
DEREK MILLER	Officer	Feb 18 '25	Proposed Sale	292.56	500	146,279		Feb 18 04:10 PM
Gordon Murdo	EVP, Global Commercial Ops	Feb 11 '25	Sale	294.79	8,771	2,585,644	44,186	Feb 13 09:02 PM
Gordon Murdo	Officer	Feb 11 '25	Proposed Sale	295.30	8,771	2,590,076		Feb 11 03:01 PM
Graham Jonathan P	EVP & Gen. Counsel & Secy.	Feb 07 '25	Option Exercise	156.35	25,045	3,915,786	54,032	Feb 10 09:52 PM
Graham Jonathan P	EVP & Gen. Counsel & Secy.	Feb 07 '25	Sale	293.12	25,045	7,341,123	28,987	Feb 10 09:52 PM
Graham Jonathan P	Officer	Feb 07 '25	Proposed Sale	292.94	25,045	7,336,682		Feb 07 03:05 PM
Grygiel Nancy A.	SVP & CCO	Feb 05 '25	Sale	304.47	1,589	483,808	7,210	Feb 06 08:54 PM
Grygiel Nancy A.	Officer	Feb 05 '25	Proposed Sale	304.47	1,589	483,800		Feb 05 12:53 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMGN

AMGEN Inc

Upgrade your FINVIZ experience